-
Signature
-
/s/ Oleg Nodelman
-
Stock symbol
-
ZYME
-
Transactions as of
-
Feb 17, 2025
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
2/18/2025, 03:48 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
holding |
ZYME |
Common Stock |
|
|
|
|
|
15.7M |
Feb 17, 2025 |
See Note |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
ZYME |
Pre-Funded Warrants |
|
|
|
|
|
|
Feb 17, 2025 |
Common Stock |
5.09M |
$0.00 |
See Note |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Mr. Nodelman is filing this Form 3 to report that he was appointed to the issuer's board of directors on February 17, 2025. Mr. Nodelman previously reported his beneficial ownership of the securities included in this report in the Forms 3 and Forms 4 filed by EcoR1 Capital, LLC.